The Anti-atherogenic Potential of Liposome-mediated Delivery of LXR Agonists to Macrophages: a Preclinical Validation Study

Author(s):
Hoekstra, M. (0000-0001-7463-2893); Geerling, J.J.; Jiskoot, W. (0000-0002-1012-3456); Eck, M. van (0000-0003-3936-3194)
Published
2018
Publication type
Article / Letter to editor
Nuclear receptorAtherosclerosisHepatic steatosisT0901317LiposomesHyperlipidemicFatty acid synthaseAortic rootAortic archCD68Hepatocyte
Date issued
2018-06-05
Language
English
Is part of
Atherosclerosis Supplements (2018), Vol. 32, p. 7
hdl
1887/73416
doi
10.1016/j.atherosclerosissup.2018.04.021